Partially Hydrolyzed Formula in Cow's Milk Protein Allergy After 6 Months of Elimination
Conditions: Cow ' s Milk Protein Allergy Interventions: Dietary Supplement: Partially hydrolyzed formula Sponsors: Ain Shams University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2023 Category: Research Source Type: clinical trials
Establishment of Biobank of Nasal Epithelium Samples From Healthy Volunteers
Conditions: Healthy Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2023 Category: Research Source Type: clinical trials
A Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital Cytomegalovirus
Conditions: Congenital Cytomegalovirus Infection Interventions: Drug: Letermovir Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2023 Category: Research Source Type: clinical trials
Quality of Life in Food Allergy: Validation of Three Mini-questionnaires
Conditions: Food Allergy Interventions: Other: Quality of Life Questionnaire Sponsors: Centre Hospitalier Universitaire de Besancon; University Hospital, Angers; University Hospital, Toulouse; Hospices Civils de Lyon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2023 Category: Research Source Type: clinical trials
Alleged Drug Allergies in Military General Medicine: Patients' Experiences and Beliefs
Conditions: Allergy Penicillin Interventions: Other: Interview Sponsors: Direction Centrale du Service de Sant é des Armées Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2023 Category: Research Source Type: clinical trials
Mechanistic Insights From Bronchoscopy Airway Samples
Conditions: Asthma Sponsors: University of California, San Francisco; National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2023 Category: Research Source Type: clinical trials
E-B-FAHF-2, Multi OIT and Xolair for Food Allergy
Conditions: Food Allergy Interventions: Drug: Drug: Chinese Herbal Medication; Drug: Drug: Placebo; Drug: Drug: Omalizumab Sponsors: New York Medical College; Icahn School of Medicine at Mount Sinai Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2023 Category: Research Source Type: clinical trials
Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN-103)
Conditions: Pre-Exposure Prophylaxis of HIV Infection Interventions: Drug: Lenacapavir Injection; Drug: Lenacapavir Tablet; Drug: Emtricitabine/tenofovir disoproxil fumarate (F/TDF) Sponsors: Gilead Sciences; HIV Prevention Trials Network; National Institute on Drug Abuse (NIDA); National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials
Zenyth: Motivational Interviewing-based Telehealth Intervention for Bacterial Sexually Transmitted Infection Screening
Conditions: Sexually Transmitted Diseases; Gonorrhea; Chlamydia; Syphilis; HIV Interventions: Behavioral: Motivational interviewing and specimen self-collection Sponsors: University of Michigan; National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2023 Category: Research Source Type: clinical trials
Allergan Aesthetics Announces Positive Topline Results from Two Pivotal Phase 3 Studies of TrenibotulinumtoxinE (BoNT/E) for the Treatment of Glabellar Lines
IRVINE, Calif., Oct. 24, 2023 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced positive topline results from two pivotal Phase 3 clinical studies evaluating trenibotulinumtoxinE (BoNT/E) for the treatment of... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 24, 2023 Category: Pharmaceuticals Source Type: clinical trials
Cardamom and Topical Roseomonas in Atopic Dermatitis
Conditions: Atopic Dermatitis; Eczema Interventions: Drug: Roseomonas mucosa (RSM2015) and Cardamom seeds; Drug: Placebo (sucrose) Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 24, 2023 Category: Research Source Type: clinical trials
Improved Diagnostics in Food Allergy Study
Conditions: Food Allergy Interventions: Diagnostic Test: Intranasal food challenge; Diagnostic Test: Mast cell activation test Sponsors: Imperial College London; Royal College of Surgeons, Ireland; University of Manchester Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 24, 2023 Category: Research Source Type: clinical trials
A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial of Cardamom and Topical Roseomonas in Atopic Dermatitis
Conditions: Atopic Dermatitis; Eczema Interventions: Drug: Roseomonas mucosa (RSM2015)& Cardamom seeds; Drug: Placebo (sucrose) Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 24, 2023 Category: Research Source Type: clinical trials
Observatory on Cow's Milk Protein Allergy
Conditions: Food Allergy Interventions: Other: Pepticate ® Syneo® Sponsors: Nutricia Nutrition Clinique Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2023 Category: Research Source Type: clinical trials
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
Conditions: Liver Transplant Interventions: Drug: CMV-MVA Triplex; Drug: Placebo for CMV-MVA Triplex Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2023 Category: Research Source Type: clinical trials
